The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Complementary DNA Microarrays (cDNA)-Global Market Insights and Sales Trends 2025
Synopsis
In genetics, complementary DNA (cDNA) is DNA synthesized from a single-stranded RNA (e.g., messenger RNA (mRNA) or microRNA (miRNA)) template in a reaction catalyzed by the enzyme reverse transcriptase. cDNA is often used to clone eukaryotic genes in prokaryotes. When scientists want to express a specific protein in a cell that does not normally express that protein (i.e., heterologous expression), they will transfer the cDNA that codes for the protein to the recipient cell. In molecular biology, cDNA is also generated to analyze transcriptomic profiles in bulk tissue, single cells, or single nuclei in assays such as microarrays and RNA-seq.
The global Complementary DNA Microarrays (cDNA) market size is expected to reach US$ 46 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Complementary DNA Microarrays (cDNA) in various end use industries. The expanding demands from the Oncology, Non-invasive pregnancy testing(NIPT), Hypertension and diabetes, are propelling Complementary DNA Microarrays (cDNA) market. Gene expression, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genotyping segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Complementary DNA Microarrays (cDNA) market, driven by demand from China, the second largest economy with some signs of stabilising, the Complementary DNA Microarrays (cDNA) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Complementary DNA Microarrays (cDNA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Complementary DNA Microarrays (cDNA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Complementary DNA Microarrays (cDNA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Complementary DNA Microarrays (cDNA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Complementary DNA Microarrays (cDNA) covered in this report include Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays, Arrayit, Sengenics, Biometrix Technology and Savyon Diagnostics, etc.
The global Complementary DNA Microarrays (cDNA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Global Complementary DNA Microarrays (cDNA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Complementary DNA Microarrays (cDNA) market, Segment by Type:
Gene expression
Genotyping
Genome cytogenetics
Global Complementary DNA Microarrays (cDNA) market, by Application
Oncology
Non-invasive pregnancy testing(NIPT)
Hypertension
diabetes
Nervous system diseases
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Complementary DNA Microarrays (cDNA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In genetics, complementary DNA (cDNA) is DNA synthesized from a single-stranded RNA (e.g., messenger RNA (mRNA) or microRNA (miRNA)) template in a reaction catalyzed by the enzyme reverse transcriptase. cDNA is often used to clone eukaryotic genes in prokaryotes. When scientists want to express a specific protein in a cell that does not normally express that protein (i.e., heterologous expression), they will transfer the cDNA that codes for the protein to the recipient cell. In molecular biology, cDNA is also generated to analyze transcriptomic profiles in bulk tissue, single cells, or single nuclei in assays such as microarrays and RNA-seq.
The global Complementary DNA Microarrays (cDNA) market size is expected to reach US$ 46 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Complementary DNA Microarrays (cDNA) in various end use industries. The expanding demands from the Oncology, Non-invasive pregnancy testing(NIPT), Hypertension and diabetes, are propelling Complementary DNA Microarrays (cDNA) market. Gene expression, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genotyping segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Complementary DNA Microarrays (cDNA) market, driven by demand from China, the second largest economy with some signs of stabilising, the Complementary DNA Microarrays (cDNA) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Complementary DNA Microarrays (cDNA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Complementary DNA Microarrays (cDNA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Complementary DNA Microarrays (cDNA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Complementary DNA Microarrays (cDNA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Complementary DNA Microarrays (cDNA) covered in this report include Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays, Arrayit, Sengenics, Biometrix Technology and Savyon Diagnostics, etc.
The global Complementary DNA Microarrays (cDNA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Global Complementary DNA Microarrays (cDNA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Complementary DNA Microarrays (cDNA) market, Segment by Type:
Gene expression
Genotyping
Genome cytogenetics
Global Complementary DNA Microarrays (cDNA) market, by Application
Oncology
Non-invasive pregnancy testing(NIPT)
Hypertension
diabetes
Nervous system diseases
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Complementary DNA Microarrays (cDNA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Complementary DNA Microarrays (cDNA)
1.1 Complementary DNA Microarrays (cDNA) Market Overview
1.1.1 Complementary DNA Microarrays (cDNA) Product Scope
1.1.2 Complementary DNA Microarrays (cDNA) Market Status and Outlook
1.2 Global Complementary DNA Microarrays (cDNA) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Complementary DNA Microarrays (cDNA) Market Size by Region (2018-2029)
1.4 Global Complementary DNA Microarrays (cDNA) Historic Market Size by Region (2018-2023)
1.5 Global Complementary DNA Microarrays (cDNA) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
1.6.1 North America Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
1.6.2 Europe Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
1.6.3 Asia-Pacific Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
1.6.4 Latin America Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
1.6.5 Middle East & Africa Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
2 Complementary DNA Microarrays (cDNA) Market by Type
2.1 Introduction
2.1.1 Gene expression
2.1.2 Genotyping
2.1.3 Genome cytogenetics
2.2 Global Complementary DNA Microarrays (cDNA) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Complementary DNA Microarrays (cDNA) Historic Market Size by Type (2018-2023)
2.2.2 Global Complementary DNA Microarrays (cDNA) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Complementary DNA Microarrays (cDNA) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Complementary DNA Microarrays (cDNA) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Complementary DNA Microarrays (cDNA) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Complementary DNA Microarrays (cDNA) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Complementary DNA Microarrays (cDNA) Revenue Breakdown by Type (2018-2029)
3 Complementary DNA Microarrays (cDNA) Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Non-invasive pregnancy testing(NIPT)
3.1.3 Hypertension
3.1.4 diabetes
3.1.5 Nervous system diseases
3.1.6 Other
3.2 Global Complementary DNA Microarrays (cDNA) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Complementary DNA Microarrays (cDNA) Historic Market Size by Application (2018-2023)
3.2.2 Global Complementary DNA Microarrays (cDNA) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Complementary DNA Microarrays (cDNA) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Complementary DNA Microarrays (cDNA) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Complementary DNA Microarrays (cDNA) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Complementary DNA Microarrays (cDNA) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Complementary DNA Microarrays (cDNA) Revenue Breakdown by Application (2018-2029)
4 Complementary DNA Microarrays (cDNA) Competition Analysis by Players
4.1 Global Complementary DNA Microarrays (cDNA) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Complementary DNA Microarrays (cDNA) as of 2022)
4.3 Date of Key Players Enter into Complementary DNA Microarrays (cDNA) Market
4.4 Global Top Players Complementary DNA Microarrays (cDNA) Headquarters and Area Served
4.5 Key Players Complementary DNA Microarrays (cDNA) Product Solution and Service
4.6 Competitive Status
4.6.1 Complementary DNA Microarrays (cDNA) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumnia
5.1.1 Illumnia Profile
5.1.2 Illumnia Main Business
5.1.3 Illumnia Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.1.4 Illumnia Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.1.5 Illumnia Recent Developments
5.2 Affymetrix
5.2.1 Affymetrix Profile
5.2.2 Affymetrix Main Business
5.2.3 Affymetrix Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.2.4 Affymetrix Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.2.5 Affymetrix Recent Developments
5.3 Agilent
5.3.1 Agilent Profile
5.3.2 Agilent Main Business
5.3.3 Agilent Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.3.4 Agilent Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.3.5 Scienion AG Recent Developments
5.4 Scienion AG
5.4.1 Scienion AG Profile
5.4.2 Scienion AG Main Business
5.4.3 Scienion AG Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.4.4 Scienion AG Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.4.5 Scienion AG Recent Developments
5.5 Applied Microarrays
5.5.1 Applied Microarrays Profile
5.5.2 Applied Microarrays Main Business
5.5.3 Applied Microarrays Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.5.4 Applied Microarrays Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.5.5 Applied Microarrays Recent Developments
5.6 Arrayit
5.6.1 Arrayit Profile
5.6.2 Arrayit Main Business
5.6.3 Arrayit Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.6.4 Arrayit Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.6.5 Arrayit Recent Developments
5.7 Sengenics
5.7.1 Sengenics Profile
5.7.2 Sengenics Main Business
5.7.3 Sengenics Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.7.4 Sengenics Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.7.5 Sengenics Recent Developments
5.8 Biometrix Technology
5.8.1 Biometrix Technology Profile
5.8.2 Biometrix Technology Main Business
5.8.3 Biometrix Technology Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.8.4 Biometrix Technology Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.8.5 Biometrix Technology Recent Developments
5.9 Savyon Diagnostics
5.9.1 Savyon Diagnostics Profile
5.9.2 Savyon Diagnostics Main Business
5.9.3 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.9.4 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.9.5 Savyon Diagnostics Recent Developments
5.10 WaferGen
5.10.1 WaferGen Profile
5.10.2 WaferGen Main Business
5.10.3 WaferGen Complementary DNA Microarrays (cDNA) Products, Services and Solutions
5.10.4 WaferGen Complementary DNA Microarrays (cDNA) Revenue (US$ Million) & (2018-2023)
5.10.5 WaferGen Recent Developments
6 North America
6.1 North America Complementary DNA Microarrays (cDNA) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Complementary DNA Microarrays (cDNA) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Complementary DNA Microarrays (cDNA) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Complementary DNA Microarrays (cDNA) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Complementary DNA Microarrays (cDNA) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Complementary DNA Microarrays (cDNA) Market Dynamics
11.1 Complementary DNA Microarrays (cDNA) Industry Trends
11.2 Complementary DNA Microarrays (cDNA) Market Drivers
11.3 Complementary DNA Microarrays (cDNA) Market Challenges
11.4 Complementary DNA Microarrays (cDNA) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
